{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T04:44:20Z","timestamp":1790397860006,"version":"4.1.0"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,8,12]],"date-time":"2021-08-12T00:00:00Z","timestamp":1628726400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,8,12]],"date-time":"2021-08-12T00:00:00Z","timestamp":1628726400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100002889","name":"Foundation for Prader-Willi Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002889","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Ophthalmol"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>There is a relative lack of information on the incidence and treatment of vision problems in Prader-Willi syndrome (PWS). Using data from the Global PWS Registry, we performed a cross-sectional study of vision problems in PWS.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Data, reported by caregivers who completed the Vision Survey in the Global PWS Registry between May of 2015 and March of 2020, were analyzed using descriptive statistics.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>There were 908 participants in this survey, with a mean age of 14.5 years (range 0\u201362 years). The prevalence of strabismus in this population was 40\u2009%, with no statistically significant difference in prevalence by genetic subtype. Ninety-one percent of participants with strabismus were diagnosed before 5 years of age. Of those with strabismus, 42\u2009% went on to have strabismus surgery, with 86\u2009% of those having their first strabismus surgery before 5 years of age and 10.1\u2009% having more than one strabismus surgery. Additional vision issues reported included myopia (41\u2009%), hyperopia (25\u2009%), astigmatism (25\u2009%), and amblyopia (16\u2009%).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>The prevalence of strabismus, amblyopia, and hyperopia are considerably higher in the PWS population represented in the Global PWS Registry as compared to the general population. People with PWS should be screened early and regularly for vision problems.<\/jats:p><\/jats:sec>","DOI":"10.1186\/s12886-021-02057-4","type":"journal-article","created":{"date-parts":[[2021,8,12]],"date-time":"2021-08-12T01:02:16Z","timestamp":1628730136000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Incidence of strabismus, strabismus surgeries, and other vision conditions in Prader-Willi syndrome: data from the Global Prader-Willi Syndrome Registry"],"prefix":"10.1186","volume":"21","author":[{"given":"Jessica E.","family":"Bohonowych","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline J.","family":"Vrana-Diaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer L.","family":"Miller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shawn E.","family":"McCandless","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theresa V.","family":"Strong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,8,12]]},"reference":[{"key":"2057_CR1","unstructured":"Driscoll DJ, Miller JL, Schwartz S, Cassidy S. Prader-Willi Syndrome. Adam M, Ardinger H, Pagon R, editors. Seattle (WA): University of Washington, Seattle. GeneReviews 2017."},{"issue":"1","key":"2057_CR2","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1038\/gim.0b013e31822bead0","volume":"14","author":"SB Cassidy","year":"2012","unstructured":"Cassidy SB, Schwartz S, Miller JL, Driscoll DJ. Prader-Willi syndrome. Genet Med. 2012;14(1):10\u201326.","journal-title":"Genet Med"},{"issue":"12","key":"2057_CR3","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1007\/s40618-015-0312-9","volume":"38","author":"MA Angulo","year":"2015","unstructured":"Angulo MA, Butler MG, Cataletto ME. Prader-Willi syndrome: A review of clinical, genetic, and endocrine findings. J Endocrinol Invest. 2015;38(12):1249\u201363.","journal-title":"J Endocrinol Invest"},{"issue":"4","key":"2057_CR4","doi-asserted-by":"publisher","first-page":"207","DOI":"10.2174\/1573396315666190716120925","volume":"15","author":"MG Butler","year":"2019","unstructured":"Butler MG, Miller JL, Forster JL. Prader-Willi Syndrome - Clinical Genetics, Diagnosis and Treatment Approaches: An Update. Curr Pediatr Rev. 2019;15(4):207\u201344.","journal-title":"Curr Pediatr Rev."},{"key":"2057_CR5","doi-asserted-by":"crossref","unstructured":"Bakker NE, Kuppens RJ, Siemensma EPC, Tummers-De LindWijngaarden Van Wijngaarden RFA, Festen DAM, Bindels-De Heus GCB, et al. Eight Years of Growth Hormone Treatment in Children With Prader-Willi Syndrome: Maintaining the Positive Effects. J Clin Endocrinol Metab. 2013;98(10):4013\u201322.","DOI":"10.1210\/jc.2013-2012"},{"issue":"1","key":"2057_CR6","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1111\/jcpp.12601","volume":"58","author":"EM Dykens","year":"2017","unstructured":"Dykens EM, Roof E, Hunt-Hawkins H. Cognitive and adaptive advantages of growth hormone treatment in children with Prader-Willi syndrome. J Child Psychol Psychiatry Allied Discip. 2017;58(1):64\u201374.","journal-title":"J Child Psychol Psychiatry Allied Discip"},{"issue":"7","key":"2057_CR7","doi-asserted-by":"publisher","first-page":"2307","DOI":"10.1210\/jc.2012-1182","volume":"97","author":"EPC Siemensma","year":"2012","unstructured":"Siemensma EPC, Van Tummers-de LindWijngaarden RFA, Festen DAM, Troeman ZCE, Van Alfen-van Der Velden AAEM, Otten BJ, et al. Beneficial effects of growth hormone treatment on cognition in children with prader-willi syndrome: A randomized controlled trial and longitudinal study. J Clin Endocrinol Metab. 2012;97(7):2307\u201314.","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"2057_CR8","doi-asserted-by":"publisher","first-page":"1581","DOI":"10.1210\/jcem.87.4.8414","volume":"87","author":"AL Carrel","year":"2002","unstructured":"Carrel AL, Myers SE, Whitman BY, Allen DB. Benefits of long-term GH therapy in Prader-Willi Syndrome: a 4-year study. J Clin Endocrinol Metab. 2002;87(4):1581\u20135.","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"2057_CR9","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1159\/000145019","volume":"70","author":"AC Lindgren","year":"2008","unstructured":"Lindgren AC, Lindberg A. Growth hormone treatment completely normalizes adult height and improves body composition in Prader-Willi syndrome: experience from KIGS (Pfizer international growth database). Horm Res. 2008;70(3):182\u20137.","journal-title":"Horm Res."},{"key":"2057_CR10","doi-asserted-by":"crossref","unstructured":"Deal CL, Tony M, Ho\u00ffbye C, Allen DB, Tauber M, Christiansen JS, et al. Growth hormone research society workshop summary: consensus guidelines for recombinant human growth hormone therapy in Prader-Willi syndrome. J Clin Endocrinol Metab.\u00a02013;98(6):E1072\u2013E1087.","DOI":"10.1210\/jc.2012-3888"},{"issue":"5","key":"2057_CR11","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1002\/ca.22686","volume":"29","author":"BJ Hurren","year":"2016","unstructured":"Hurren BJ, Flack NAMS. Prader\u2013Willi Syndrome: A spectrum of anatomical and clinical features. Clin Anat. 2016;29(5):590\u2013605.","journal-title":"Clin Anat"},{"issue":"713","key":"2057_CR12","first-page":"1","volume":"10","author":"J Bohonowych","year":"2019","unstructured":"Bohonowych J, Miller J, McCandless S, Strong T. The Global Prader-Willi Syndrome Registry: Development, Launch, and Early Demographics. Genes (Basel). 2019;10(713):1\u201314.","journal-title":"Genes (Basel)."},{"issue":"7","key":"2057_CR13","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1016\/j.ophtha.2007.08.001","volume":"115","author":"The Multi-ethnic Pediatric Eye Disease Study Group","year":"2008","unstructured":"The Multi-ethnic Pediatric Eye Disease Study Group. Prevalence of Amblyopia and Strabismus in African American and Hispanic Children Ages 6 to 72 Months: The Multi-ethnic Pediatric Eye Disease Study Multi-ethnic Pediatric Eye Disease Study Group * HHS Public Access. Ophthalmology. 2008;115(7):1229\u201336.","journal-title":"Ophthalmology"},{"issue":"10","key":"2057_CR14","doi-asserted-by":"publisher","first-page":"2117","DOI":"10.1016\/j.ophtha.2013.03.001","volume":"120","author":"R McKean-Cowdin","year":"2013","unstructured":"McKean-Cowdin R, Cotter SA, Tarczy-Hornoch K, Wen G, Kim J, Borchert M, et al. Prevalence of amblyopia or strabismus in Asian and non-Hispanic white preschool children: Multi-ethnic pediatric eye disease study. Ophthalmology. 2013;120(10):2117\u201324.","journal-title":"Ophthalmology"},{"issue":"11","key":"2057_CR15","doi-asserted-by":"publisher","first-page":"2128","DOI":"10.1016\/j.ophtha.2009.04.034","volume":"116","author":"DS Friedman","year":"2009","unstructured":"Friedman DS, Repka MX, Katz J, Giordano L, Ibironke J, Hawse P, et al. Prevalence of Amblyopia and Strabismus in White and African American Children Aged 6 through 71 Months. The Baltimore Pediatric Eye Disease Study. Ophthalmology. 2009;116(11):2128.","journal-title":"Ophthalmology"},{"issue":"10","key":"2057_CR16","doi-asserted-by":"publisher","first-page":"1646","DOI":"10.1016\/j.ophtha.2018.04.024","volume":"125","author":"M Repka","year":"2018","unstructured":"Repka M, Lum F, Burugapalli B. Strabismus, Strabismus Surgery, and Reoperation Rate in the United States: Analysis from the IRIS Registry. Ophthalmology. 2018;125(10):1646\u201353.","journal-title":"Ophthalmology"},{"issue":"1","key":"2057_CR17","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1111\/cge.13947","volume":"100","author":"R Mahmoud","year":"2021","unstructured":"Mahmoud R, Leonenko A, Butler M, Flodman P, Gold J, Mille J, et al. Influence of molecular classes and growth hormone treatment on growth and dysmorphology in Prader-Willi syndrome: a multicenter study. Clin Genet. 2021;100(1):29\u201339.","journal-title":"Clin Genet"},{"issue":"1","key":"2057_CR18","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1002\/ajmg.a.61408","volume":"182","author":"J Oldzej","year":"2020","unstructured":"Oldzej J, Manazir J, Gold JA, Mahmoud R, Osann K, Flodman P, et al. Molecular subtype and growth hormone effects on dysmorphology in Prader\u2013Willi syndrome. Am J Med Genet Part A. 2020;182(1):169\u201375.","journal-title":"Am J Med Genet Part A"},{"issue":"3","key":"2057_CR19","doi-asserted-by":"publisher","first-page":"145","DOI":"10.3928\/0191-3913-19880501-10","volume":"25","author":"RW Hered","year":"1988","unstructured":"Hered RW, Rogers S, Zang YF, Biglan AW. Ophthalmologic features of Prader-Willi syndrome. J Pediatr Opthalmology Strabismus. 1988;25(3):145\u201350.","journal-title":"J Pediatr Opthalmology Strabismus"},{"issue":"1","key":"2057_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2415-14-163","volume":"14","author":"VD Castagno","year":"2014","unstructured":"Castagno VD, Fassa AG, Carret MLV, Vilela MAP, Meucci RD. Hyperopia: A meta-analysis of prevalence and a review of associated factors among school-aged children. BMC Ophthalmol. 2014;14(1):1\u201319.","journal-title":"BMC Ophthalmol."},{"issue":"8","key":"2057_CR21","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1001\/archopht.126.8.1111","volume":"126","author":"S Vitale","year":"2008","unstructured":"Vitale S, Ellwein L, Cotch MF, Ferris FL, Sperduto R. Prevalence of refractive error in the United States, 1999\u20132004. Arch Ophthalmol. 2008;126(8):1111\u20139.","journal-title":"Arch Ophthalmol"},{"key":"2057_CR22","doi-asserted-by":"publisher","first-page":"1581","DOI":"10.2147\/OPTH.S164641","volume":"12","author":"C Theophanous","year":"2018","unstructured":"Theophanous C, Modjtahedi BS, Batech M, Marlin DS, Luong TQ, Fong DS. Myopia prevalence and risk factors in children. Clin Ophthalmol. 2018;12:1581\u20137.","journal-title":"Clin Ophthalmol"}],"container-title":["BMC Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12886-021-02057-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12886-021-02057-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12886-021-02057-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,7]],"date-time":"2023-01-07T05:05:35Z","timestamp":1673067935000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcophthalmol.biomedcentral.com\/articles\/10.1186\/s12886-021-02057-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,12]]},"references-count":22,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["2057"],"URL":"https:\/\/doi.org\/10.1186\/s12886-021-02057-4","relation":{},"ISSN":["1471-2415"],"issn-type":[{"value":"1471-2415","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,8,12]]},"assertion":[{"value":"7 April 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 July 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 August 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the New England Institutional Review Board (IRB #120190361) and informed consent was obtained from subjects or if subjects were under 18, from a parent and\/or legal guardian. All methods were carried out in accordance with relevant guidelines and regulations.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"J.E.B., C.J.V-D, and T.V.S. are employees of the Foundation for Prader\u2013Willi Research. J.M and S.E.M declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"296"}}